Riddhi Siddhi Gluco Biols Limited
BSE:524480 Rapport sur les actions
Capitalisation boursière : ₹4.7b
Ajouter à la liste de surveillanceRiddhi Siddhi Gluco Biols Bilan de santé
Santé financière contrôle des critères 4/6 Riddhi Siddhi Gluco Biols possède un total de capitaux propres de ₹15.9B et une dette totale de ₹727.5M, ce qui porte son ratio d'endettement à 4.6%. Son actif total et son passif total sont ₹17.7B et de ₹1.8B.
Informations clés Ratio de couverture des intérêts n/a Argent liquide ₹441.61m Fonds propres ₹15.92b Total du passif ₹1.82b Total des actifs ₹17.74b
Mises à jour récentes de la santé financière
Afficher toutes les mises à jour
Upcoming dividend of ₹3.00 per share Sep 11 Riddhi Siddhi Gluco Biols Limited to Report First Half, 2025 Results on Nov 14, 2024
Investor sentiment improves as stock rises 15% Aug 27
Riddhi Siddhi Gluco Biols Limited, Annual General Meeting, Sep 25, 2024 Aug 16
Dividend increased to ₹3.00 Aug 16
Riddhi Siddhi Gluco Biols Limited to Report Q1, 2025 Results on Aug 14, 2024 Aug 09
Investor sentiment improves as stock rises 17% Jul 10
Full year 2024 earnings released: EPS: ₹61.53 (vs ₹46.15 in FY 2023) May 21
Third quarter 2024 earnings released: EPS: ₹11.74 (vs ₹6.14 in 3Q 2023) Feb 13
Investor sentiment improves as stock rises 23% Jan 01
New major risk - Share price stability Nov 10
Second quarter 2024 earnings released: EPS: ₹16.44 (vs ₹2.99 in 2Q 2023) Nov 06
Riddhi Siddhi Gluco Biols Limited to Report Q2, 2024 Results on Nov 04, 2023 Oct 29
Upcoming dividend of ₹1.50 per share at 0.3% yield Sep 11
Riddhi Siddhi Gluco Biols Limited, Annual General Meeting, Sep 26, 2023 Sep 05
Riddhi Siddhi Gluco Biols Limited Announces Resignation of Mrs. Urvi Desai as Non - Executive Independent Director Sep 02
Riddhi Siddhi Gluco Biols Limited Announces Resignation of Mrs. Urvi Desai as Non - Executive Independent Director Sep 01
Insufficient new directors Sep 01
New minor risk - Share price stability Aug 22
Investor sentiment improves as stock rises 17% Aug 21
First quarter 2024 earnings released: EPS: ₹8.64 (vs ₹6.56 in 1Q 2023) Aug 13
New minor risk - Dividend sustainability Jun 12
Full year 2023 earnings released: EPS: ₹46.83 (vs ₹20.09 in FY 2022) Jun 03
Riddhi Siddhi Gluco Biols Limited to Report Q4, 2023 Results on May 29, 2023 May 25
Third quarter 2023 earnings released: EPS: ₹6.14 (vs ₹10.78 loss in 3Q 2022) Feb 17
Riddhi Siddhi Gluco Biols Limited to Report Q3, 2023 Results on Feb 14, 2023 Feb 10
Second quarter 2023 earnings released: EPS: ₹2.99 (vs ₹30.79 in 2Q 2022) Nov 20
Investor sentiment improved over the past week Nov 03
Upcoming dividend of ₹1.00 per share Sep 08
Riddhi Siddhi Gluco Biols Limited, Annual General Meeting, Sep 24, 2022 Aug 26
First quarter 2023 earnings released: EPS: ₹6.56 (vs ₹3.52 in 1Q 2022) Aug 08
Full year 2022 earnings released: EPS: ₹20.09 (vs ₹65.62 loss in FY 2021) Jun 03
Riddhi Siddhi Gluco Biols Limited Recommends Dividend for the Financial Year Ended March 31, 2022 May 31
Riddhi Siddhi Gluco Biols Limited to Report Q4, 2022 Results on May 30, 2022 May 24
Investor sentiment improved over the past week Apr 06
Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint Feb 15
Full year 2021 earnings released: ₹65.62 loss per share (vs ₹46.11 profit in FY 2020) Jun 02
New 90-day high: ₹276 Mar 16
Third quarter 2021 earnings released: ₹35.61 loss per share (vs ₹22.50 profit in 3Q 2020) Feb 15
Riddhi Siddhi Gluco Biols Limited to Report Q3, 2021 Results on Feb 12, 2021 Feb 06
New 90-day high: ₹267 Dec 29
Second quarter 2021 earnings released: ₹14.58 loss per share Nov 13
Riddhi Siddhi Gluco Biols Limited to Report Q2, 2021 Results on Nov 10, 2020 Nov 05
New 90-day low - ₹254 Sep 11
First quarter earnings released Aug 30
Riddhi Siddhi Gluco Biols Limited to Report Q1, 2021 Results on Aug 29, 2020 Aug 21
Analyse de la situation financière
Passif à court terme: Les actifs à court terme de 524480 ( ₹6.8B ) dépassent ses passifs à court terme ( ₹1.7B ).
Passif à long terme: Les actifs à court terme de 524480 ( ₹6.8B ) dépassent ses passifs à long terme ( ₹143.1M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de 524480 ( 1.8% ) est considéré comme satisfaisant .
Réduire la dette: Le ratio d'endettement de 524480 a été réduit de 22.8% à 4.6% au cours des 5 dernières années.
Couverture de la dette: La dette de 524480 n'est pas bien couverte par le flux de trésorerie opérationnel ( 12.2% ).
Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de 524480 sur sa dette sont bien couverts par l' EBIT .
Découvrir des entreprises saines Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}